Ronit Simantov - 27 Jan 2026 Form 4 Insider Report for Tempest Therapeutics, Inc. (TPST)

Role
Director
Signature
/s/ Nicholas Maestas, Attorney-in-Fact
Issuer symbol
TPST
Transactions as of
27 Jan 2026
Net transactions value
$0
Form type
4
Filing time
28 Jan 2026, 16:30:13 UTC
Previous filing
14 Jun 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Simantov Ronit Director C/O TEMPEST THERAPEUTICS, INC., 2000 SIERRA POINT PARKWAY, SUITE 400, BRISBANE /s/ Nicholas Maestas, Attorney-in-Fact 28 Jan 2026 0001871563

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPST Stock Option (right to buy) Award $0 +1,230 $0.000000 1,230 27 Jan 2026 Common Stock 1,230 $2.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the option will vest in full on the earlier of (i) January 27, 2027, or (ii) the day of the Issuer's 2026 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date.